The rise of injectable peptides, fueled by social media trends and a global supply, is causing a surge in demand for harm-reduction services in Western Australia. This trend, while still a smaller portion of overall illicit drug use, is alarming due to the lack of regulation and research surrounding these synthetic substances. The Therapeutic Goods Administration's recent crackdown on unapproved peptides is a necessary step to address public health concerns, but the underlying issue of easy access and influence from social media influencers persists. The Peer Based Harm Reduction (PBHR) service, which operates the largest needle and syringe exchange program in WA, has seen a dramatic increase in the number of people accessing equipment for synthetic peptide use in the past three years. This shift in demographics, from elite athletes to everyday individuals, highlights the growing popularity and accessibility of these substances. The concern is not only about the potential for misuse but also the inherent risks associated with unregulated markets, including the possibility of contaminated substances and unknown long-term health effects. As the demand for peptides rises, there is an urgent need for research investment to understand the risks and develop effective prevention strategies. The situation underscores the importance of public health education and regulation to mitigate the potential harm caused by the misuse of synthetic peptides.
